CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 160.8 SEK -2.19% Market Closed
Market Cap: 3.8B SEK

CellaVision AB
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CellaVision AB
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Pre-Tax Income
kr176.9m
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
15%
Elekta AB (publ)
STO:EKTA B
Pre-Tax Income
kr1.7B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Pre-Tax Income
kr158.1m
CAGR 3-Years
34%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Pre-Tax Income
kr2.3B
CAGR 3-Years
-18%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Pre-Tax Income
kr684m
CAGR 3-Years
-12%
CAGR 5-Years
5%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Pre-Tax Income
kr69.2m
CAGR 3-Years
50%
CAGR 5-Years
19%
CAGR 10-Years
43%

CellaVision AB
Glance View

Market Cap
3.8B SEK
Industry
Health Care

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

CEVI Intrinsic Value
256.67 SEK
Undervaluation 37%
Intrinsic Value
Price

See Also

What is CellaVision AB's Pre-Tax Income?
Pre-Tax Income
176.9m SEK

Based on the financial report for Dec 31, 2024, CellaVision AB's Pre-Tax Income amounts to 176.9m SEK.

What is CellaVision AB's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
15%

Over the last year, the Pre-Tax Income growth was 8%. The average annual Pre-Tax Income growth rates for CellaVision AB have been 4% over the past three years , 6% over the past five years , and 15% over the past ten years .

Back to Top